Loading data
NDRANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 1.85 m USD | 3.19 m USD | 5 m USD | 6.55 m USD | 5.48 m USD |
| Operating profit | -5.76 m USD | -10.82 m USD | -10.52 m USD | -13.16 m USD | -11.5 m USD |
| Profit before tax | -7.03 m USD | -11.51 m USD | -10.06 m USD | -13.18 m USD | -11.23 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -7.03 m USD | -11.51 m USD | -10.06 m USD | -13.18 m USD | -11.23 m USD |
| Net income attributable to common shareholders | — | — | — | -13.18 m USD | -11.35 m USD |
| Basic earnings per share | -8.93 USD/share | -56.94 USD/share | — | -4.56 USD/share | -5.55 USD/share |
| Diluted earnings per share | -8.93 USD/share | -56.94 USD/share | -2,766.85 USD/share | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.